Axonics (AXNX) announced that its stockholders have voted to adopt Axonics’ merger agreement with Boston Scientific (BSX). The closing of the transaction is expected to occur in the first half of 2024 and remains subject to certain conditions, including receipt of approvals or clearances, or the expiration, termination or waiver of applicable waiting periods under U.S. and foreign antitrust laws.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
